Protagenic Therapeutics (PTIX) — Free Cash Flow Generation Index
Protagenic Therapeutics (PTIX) has a Free Cash Flow Generation Index of 1.00x as of December 2010. Free cash flow of $1.72 Million represents 1% of operating cash flow ($1.72 Million). Explore Protagenic Therapeutics (PTIX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Protagenic Therapeutics Free Cash Flow Generation Index (1999–2008)
Historical FCF Generation Index trend for Protagenic Therapeutics across 7 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Protagenic Therapeutics.
Annual Free Cash Flow Generation for Protagenic Therapeutics (1999–2008)
Year-by-year Free Cash Flow Generation Index for Protagenic Therapeutics. Check PTIX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2008 | 0.53x | $2.33 Million | $4.36 Million | $2.03 Million | ▼ -41.8% |
| 2006 | 0.92x | $854.00K | $931.00K | $77.00K | ▲ +339.8% |
| 2003 | 0.21x | $390.00K | $1.87 Million | $1.48 Million | ▼ -13.1% |
| 2002 | 0.24x | $563.00K | $2.35 Million | $1.78 Million | ▲ +115.8% |
| 2001 | -1.52x | $-2.29 Million | $1.50 Million | $3.79 Million | ▼ -2017.1% |
| 2000 | 0.08x | $278.00K | $3.51 Million | $3.23 Million | ▼ -89.5% |
| 1999 | 0.76x | $250.00K | $331.00K | $81.00K | — |